BioNTech SE

( )
BNTX PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
MRNAModerna, Inc. 0.43%158.310.0%$4788.86m
NVAXNovavax, Inc. 0.00%129.1692.9%$692.15m
BIIBBiogen, Inc. 0.00%244.091.7%$657.62m
BNTXBioNTech SE -1.90%116.420.0%$643.80m
AMGNAmgen, Inc. 0.00%226.911.3%$592.96m
GILDGilead Sciences, Inc. 0.00%60.861.0%$518.30m
VRTXVertex Pharmaceuticals, Inc. 0.00%226.871.9%$485.44m
REGNRegeneron Pharmaceuticals, Inc. 0.00%498.842.7%$482.97m
ILMNIllumina, Inc. 0.00%346.003.5%$428.45m
EXASEXACT Sciences Corp. 0.00%130.6719.6%$199.30m
APVOAptevo Therapeutics, Inc. 0.00%45.9918.3%$174.42m
SGENSeagen Inc. 0.00%180.165.8%$171.25m
ALXNAlexion Pharmaceuticals, Inc. 0.00%121.062.0%$141.98m
SRNESorrento Therapeutics, Inc. 0.13%7.981.4%$135.93m
BGNEBeiGene Ltd. 0.00%221.311.4%$135.66m

Company Profile

BioNTech SE operates as a clinical-stage biotechnology company. It operates through the following business units: Biotech Business and External Services. The Biotech Business unit consists of Clinical, Technology Platform and Manufacturing segments. It also includes business services operations. The External Services unit consists of External Services segment, which includes activities related to the sale of diagnostic products, peptides, retroviral vectors for clinical supply, development and manufacturing services. The company was founded by Christopher Huber, Ozlem Tureci and Ugur Sahin on June 2, 2008 and is headquartered in Mainz, Germany.